Security key
04351P101
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 23,269,447
- Total 13F value
- $646,000,000
- Share change
- +2,893,015
- SEC-reported price per share
- $27.76
- Number of holders
- 34
- Value change
- +$80,276,736
- Number of buys
- 20
- Number of sells
- 13
- Shares outstanding
- 62,915,156
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2017
Institutions
34
Top holders
10
ASND full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2017
Previous quarter: Q1 2017
Ascendis Pharma A/S SEC filings
Ascendis Pharma A/S company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04351P101
Recent filing periods:
Ownership snapshot
Top reported holders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
31 Mar 2017
13F
Lead comparable stake: 8.6%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 8.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
8.6%
FMR LLC
5.1%
ORBIMED ADVISORS LLC
4.3%
Vivo Capital, LLC
2.8%
BAKER BROS. ADVISORS LP
2.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
8.6%
|
$151,480,000
5,409,990 shares
|
— | 31 Mar 2017 |
| FMR LLC |
13F
Company
|
5.1%
|
$90,685,000
3,238,720 shares
|
— | 31 Mar 2017 |
| ORBIMED ADVISORS LLC |
13F
Company
|
4.3%
|
$76,085,000
2,717,315 shares
|
— | 31 Mar 2017 |
| Vivo Capital, LLC |
13F
Company
|
2.8%
|
$49,471,000
1,766,832 shares
|
— | 31 Mar 2017 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
2.1%
|
$37,841,000
1,351,463 shares
|
— | 31 Mar 2017 |
| EcoR1 Capital, LLC |
13F
Company
|
1.6%
|
$28,720,000
1,025,700 shares
|
— | 31 Mar 2017 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
34
Shares
23,269,447
Rows available
34
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2017 vs Q1 2017 Across Filers
Q1 2017 holders
34
Q2 2017 holders
34
Holder diff
0
| Investor | Q1 2017 Shares | Q2 2017 Shares | Share Diff | Share Chg % | Q1 2017 value | Q2 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend